Evaluation of the prevalence of non-alcoholic fatty liver disease (and steatohepatitis) in patients with type 2 diabetes mellitus

• Conditions: fatty liver; NASH; 10012653; 10017969; 10013317

• Registration Number: NL-OMON29718
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 1500

Inclusion Criteria

All type 2 diabetes mellitus patients visiting the outpatient clinic internal medicine of the Sint Lucas Andreas Hospital Amsterdam

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Disturbed liver enzymes (i.e. AP, gammaGt, ASAT and ALAT)<br /><br>Increased hepatic echogenicity (hepatic steatosis)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>